LEN vs TMCI · rev $34.19B vs rev $209.4M
LEN (LEN) versus Treace Medical Concepts Inc (TMCI) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported TMCI revenue for 2024-12-31 was $209.4M. Net income was -$55.7M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. TMCI currently screens at market cap $260.1M.
LEN currently screens at market cap $0. TMCI currently screens at market cap $260.1M.
Not investment advice. Open the LEN and TMCI stock pages for the full models.
Not investment advice.